Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder.
CNS Drugs December 1, 2024 Ruyun Liu, Ning Liu, Lin Ma et al. 5 citations
Major depressive disorder (MDD) is a severe mental illness with a complex etiology. Currently, many medications employed in clinical treatment exhibit limitations such as delayed onset of action and a high incidence of adverse reactions. Therefore, there is a pressing need to develop antidepressants that exhibit enhanced efficacy and safety. The N-methyl-D-aspartate receptor (NMDAR), a...